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Abstract
The Epithelial Sodium Channel (ENaC) is a key player in renal sodium homeostasis. The
expression of α β γ ENaC subunits has also been described in the endothelium and vascular
smooth muscle, suggesting a role in vascular function. We recently demonstrated that endo-
thelial ENaC is involved in aldosterone-modulated endothelial stiffness. Here we explore the
functional role of the endothelial αENaC subunit in vascular function in vivo. Compared to lit-
termates, mice with conditional αENaC subunit gene inactivation in the endothelium only
(endo-αENaC Knock Out mice) had no difference in their physiological parameters such as
systolic blood pressure or heart rate. Acute and long-term renal Na+ handlings were not
affected, indicating that endothelial αENaC subunit is not involved in renal sodium balance.
Pharmacological inhibition of ENaC with benzamil blunted acetylcholine-induced nitric oxide
production in mesenteric arteries from wild type mice but not in endo-αENaC KO mice, sug-
gesting a critical role of endothelial ENaC in agonist-induced nitric oxide production. In
endo-αENaC KO mice, compensatory mechanisms occurred and steady state vascular func-
tion was not altered except for flow-mediated dilation. Our data suggest that endothelial
αENaC contributes to vascular endothelial function in vivo.
Introduction
The endothelium is a thin monolayer of cells that line the interior surface of entire blood ves-
sels, forming a physical barrier between circulating blood element and underlying tissues.
Endothelial cells are involved in many aspects of vascular biology, including the response to
shear force, modulation of blood vessel tone and blood flow [1], thus playing an important
role in blood pressure regulation. However, the way how endothelial cells are able to sense the
mechanical force produced by the pulsatile circulating blood and translate it into a molecular
signal remains unknown. Several actors have been suggested as endothelial mechanosensors
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and among them, ion channels. Ion channels expressed in endothelial cells are considered to
mediate “short term” responses (in the range of seconds and minutes) to shear stress and
subsequently affect cytoskeleton rearrangement and synthesis and/or release of pro and anti-
coagulants, growth factors and vasomotor regulators [2]. Among these ion channels, a new
candidate has rose these last decades: the Epithelial Sodium Channel (ENaC). ENaC is a
sodium channel member of the ENaC/Degenerin superfamily, which includes the Degenerins
subunits that act as mechanosensors in Caenorhabditis elegans [3, 4]. ENaC has been described
in the endothelium for fifteen years, but its role in cell function and in vascular biology re-
mains largely unknown [5–8].
ENaC is expressed in the renal epithelium where it is one of the key players responsible for
the fine tuning of sodium reabsorption. ENaC is composed of three subunits (αENaC, βENaC
and γENaC coded, respectively, by the genes Scnn1a, Scnn1b and Scnn1g), forming a channel
expressed at the apical membrane of the cells, thus allowing sodium entry through the renal
epithelium [9–11]. Regulation of sodium homeostasis is a crucial physiological process, as it
maintains renal salt and water balance, blood volume, and consequently blood pressure [12,
13]. There is now evidence that ENaC opening probability is regulated by flow-induced shear
stress in oocyte and in the epithelium of cortical collecting duct [14], which highlights its impl-
ication in the detection of mechanical forces (and its potential role as a direct mechanosensor).
As in the renal collecting duct (where the epithelial cells are submitted to urine flow-
induced laminar shear stress), the endothelial cells support blood flow-induced laminar shear
stress, thus raising the potential implication of shear stress sensing in vascular endothelium. In
cultured vascular endothelial cells, ENaC mediates amiloride-sensitive Na+ currents [6–8].
Interestingly, its channel activity and its opening probability have been showed to be regulated
by flow-induced shear stress [7, 8]. Moreover, endothelial ENaC has been reported to be
involved in mechanical properties of endothelial cell: increased endothelial ENaC expression
or activity increases endothelial cell stiffness both in cultured human endothelial cells and in
aorta of Liddle syndrome mouse model [15]. Among the three subunits, αENaC has been
shown to be necessary and sufficient to produce an inward sodium current [11] and Jeggle
et al. showed that the aENaC subunit by itself could alter endothelial cortical stiffness [15]. The
consequences of pharmacological inhibition of vascular ENaC has been studied ex vivo [6, 8].
However, the role of endothelial ENaC on vascular function in vivo has not been analyzed so
far. Since ENaC is activated by flow we investigated whether it could play a role in shear stress
sensing and flow-mediated dilation in vivo.
To address this question, we focused our study on the role of the alpha ENaC in the endo-
thelium by using a constitutive knockout mouse model allowing deletion of the αENaC sub-
unit in the endothelial cells.
Materials and methods
Mouse models
αENaC subunit (Scnn1a) knockout mice, thereafter called endo-αENaC KO, were obtained
crossing αENaCf/f floxed mice (kindly provided by Bernard Rossier, Lausanne, Switzerland
[16] with transgenic mice expressing Cre recombinase under the control of Tie2 promoter on
a C57BL/6 genetic background (The Jackson Laboratory, USA). αENaC f/f littermates lacking
the Tie2-Cre transgene were used as controls. The sequences of the primers used for genotyp-
ing are listed in S1 Table. Animals were 3-6-month-old males housed in a climate-controlled
facility with a 12-hour/12-hour light/dark cycle and provided free access to food and water.
Animals were euthanized with an intraperitoneal injection of a lethal dose of ketamine/xyla-
zine and blood was withdrawn by cardiac puncture. Organs were harvested and immediately
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conserved in formalin or snap-frozen in liquid nitrogen and stored at -80˚C unless specified
otherwise. All experiments were approved by the Charles Darwin ethics committee (C2EA–
05) of Pierre et Marie Curie University, and conducted in accordance with the European legis-
lation for the care and use of laboratory animals.
cDNA isolation and real-time PCR of ENaC subunits
Total RNA from whole kidney were extracted using the TRIZOL1 reagent (Life Technologies
Corporation, USA), according to manufacturer protocol. Aortas were extracted using RNeasy
Kit (Qiagen, Germany). Reverse transcription of mRNA (500 ng) was performed using Super-
script II Reverse Transcriptase KIT (Life Technologies Corporation, USA). Transcript levels of
genes were analyzed by real-time PCR (fluorescence detection of SYBR Green) in an iCycler
iQ (Bio-Rad, USA). For each sample, mRNA levels were normalized to the housekeeping gene,
18S (Rn18s). The sequences of the primers are listed in S1 Table (Eurogentec, Belgium).
Quantum dot-based immunofluorescence of αENaC at cell surface ex
vivo
Endothelial cells of in situ endothelial cells of ex vivo aorta preparations were fixed and stained
as described elsewhere [15, 17]. Briefly, αENaC abundance on the upper cell surface (facing
the medium) was detected and quantified via Quantum Dot (QD)-based immunofluorescence.
Therefore, a primary polyclonal rabbit anti-αENaC antibody (Santa Cruz; 1:250), a secondary
QD-labeled antibody (Qdot 655 goat anti-rabbit IgG, Invitrogen; 1:800) and DAPI (4’,6-diami-
dino-2-phenylindole; Invitrogen) were used for staining. Negative controls were established by
incubating cells solely with the secondary antibody. The specificity of the primary antibody
was recently demonstrated by using M-1 cells as positive control and siαENaC-transfected EA.
hy926 cells [15]. Staining was verified by epi-fluorescence microscopy (microscope: Leica DMI
6000B, Leica Microsystems; camera: CoolSNAPHQ, Photometrics, USA). The QD-based
immunofluorescence was quantified by counting QD/1000 μm2 of cell surface using ImageJ
software (National Institutes of Health, USA). Images were taken in 3 different sections of the
endothelial monolayer and all images were analyzed simultaneously in order to account for
any variations in cell height. Staining of all groups were performed in parallel and the QD
background derived from a negative control without primary antibody was subtracted from all
samples.
Measurement of endothelial stiffness using atomic force microscope
As previously described [18], the first ~1.5 cm of aortae, from heart to diaphragm, were dis-
sected from the mice and freed from surrounding tissue. A small patch (about 1 mm2) of the
whole aorta was prepared and attached on Cell-Tak1 coated glass, a tissue adhesive (BD Bio-
sciences, Germany), with the endothelial surface facing upwards. Prior to the experiments, the
preparations were kept in minimal essential medium (MEM) (Invitrogen Corp.) with the addi-
tion of 1% MEM vitamins, penicillin G (10,000 U/mL), streptomycin (10,000 μg/mL) (Bio-
chrome AG, Germany), 1% NEAA and 20% fetal bovine serum (PAA Clone) at 37˚C and 5%
CO2.
Mechanical stiffness of the endothelial cell cortex, a layer 50–200 nm beneath the plasma
membrane, of ex vivo aorta preparations was determined using an atomic force microscope
(AFM) nano-indentation technique [19, 20]. Stiffness measurements of living endothelial cells
ex vivo were conducted with a scanning probe microscope (MultiMode1 SPM, Bruker, USA)
with a feedback-controlled heating device (Bruker) or an atomic force microscope integrated
into an inverted fluorescence microscope (BioScope CatalystTM, Bruker; combined with DMI
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6000B, Leica Microsystems, Germany). During the measurements, artery preparations were
bathed in HEPES-buffered solution (standard composition in mM: 135 NaCl, 5 KCl, 1 MgCl2,
1 CaCl2, 10 HEPES (N-2-hydroxyethylpiperazine-N
0-2-ethanesulfonicacid, pH 7.4). AFM stiff-
ness measurements were performed using soft cantilevers (spring constant:<20 pN/nm;
Novascan) with a polystyrene sphere as the tip (diameter: 10μm). A maximal loading force of 2
nN was applied. Obtained AFM data were collected with NanoScope softwares 5.31 and V8.10
(Bruker). Stiffness values were calculated from force-distance curves using the Protein Unfold-
ing and Nano-Indentation Analysis Software PUNIAS 3D version 1.0 release 1.8 (http://
punias.voila.net).
Physiological parameters
Systolic blood pressure and heart rate were measured by tail cuff plethysmography in trained
conscious mice (three days of training). Ten measurements per mice were taken every day
between 1 p.m. and 3 p.m. during five days using a BP2000 Visitech model (Bioseb, France).
The values presented are the mean values obtained during five days.
Renal function and ions excretion were assessed using metabolic cages (Tecniplast, France).
Mice were allowed three days of habituation with food and water ad libidum. For renal func-
tion and sodium handling at basal state, urine was collected on a 24 hours period. Blood was
collected from the retro-orbital cavity.
For the acute sodium load challenge, 1 mEq of sodium chloride was given by gavage in
200 μl water. Urine was collected at 4, 8 and 24 hours after gavage. For amiloride (an ENaC
inhibitor), a dose of 1.45 g per gram of body weight was administrated via intra-peritoneal
injection in 100 μl of water. Urine was collected at 4, 8 and 24 hours after injection. Low salt
diet (0.1% NaCl, SAFE, France) was given for four days and urine was collected twice a day.
Urea and creatinine (enzymatic method) were quantified using a KONELAB (Thermo-
Fischer Scientific, USA), sodium and potassium using a flame photometer (Instrumentation
Laboratory, USA). Creatinine clearance was calculated using the equation UP  V where U is
the concentration of creatinine in urine, P is the concentration of creatinine in plasma, and V
is the urine flow rate in milliliters per minute.
Aldosterone plasma levels were measured by using a radioimmunoassay Coat-a-Count
(Siemens, Germany). Plasmatic levels of corticosterone were measured using EIA kit (Cayman
Chemical Company, USA). Assays were realized according to manufacturer’s protocols.
Measurement of nitric oxide in mesenteric arteries of mice
Mesenteric arteries from endo-αENaC KO and wild type mice were isolated, cut open and
placed with the endothelial layer facing upwards. Low levels of nitric oxide (NO) were mea-
sured with 4-amino-5-Mehtylamino-2’,7’-Difluorofluoresceince (DAF-FM) as described pre-
viously [21]. In short, vessels were incubated 4 μM DAF-FM diacetate (Molecular Probes1)
followed by wash-out. The experiments were executed at an Olympus IX71microscope and
visualized by excitation at 495 nm and emission at 515 nm. Full frame images were collected
and analyzed for relative changes in fluorescence intensity (ΔF = (F/F0)). Endothelial cells that
were in focus during the whole experiment were analyzed.
Western blot and antibodies
Western blot analysis was performed on proteins extracted from whole aortas obtained from
endo-αENaC KO and wild type mice. Samples were homogenized immediately after collection,
using 150 μl of Complete Lysis-M buffer with proteases and phosphatases inhibitors cocktail
(Roche, Switzerland). Extracts were centrifuged at 14000 rpm for 10 minutes at 4˚C and
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protein concentration in the supernatant was determined by the Pierce protein assay (Bio-
Rad, USA). Thirty micrograms of total proteins were loaded on 4–15% polyacrylamide TGX
gel (Bio-Rad, USA) and transferred to nitrocellulose membranes using Trans Blot turbo (Bio-
Rad, USA). Primary antibodies were incubated at 4˚C overnight, while secondary antibodies
were incubated 1h30 at room temperature. Membranes were stripped after detection of the
phosphorylated protein in order to detect total unphosphorylated proteins. Antibodies and
dilutions are listed in the S2 Table.
Vascular reactivity analysis
Vascular contractile and relaxing responses to pharmacological agents and flow-dependent
tone in isolated segments of mesenteric arteries were assessed as previously described [22].
Briefly, mesenteric arteries were cannulated at both ends in a video-monitored perfusion sys-
tem (LSI, Burlington, VT, USA) and bathed in a PSS of the following composition (mM): 130,
NaCl; 15, NaHCO3; 3.7, KCl; 1.2 KH2PO4; 1.2, MgSO4; 11, glucose; 1.6, CaCl2; and 5, HEPES,
pH 7.4, PO2 160 mmHg, PCO2 37 mmHg). Pressure was maintained at 75 mmHg by a servo-
perfusion system and flow was generated by a peristaltic pump. For pharmacological agents,
arterial segments reactivity was estimated using first a potassium rich solution (8.10−2 M).
After that, endothelial function was evaluated using acetylcholine (10−6 M) after precontrac-
tion with phenylephrine (10−6 M). For flow mediated dilation, diameter changes and changes
in wall thickness were measured at a set pressure of 75 mmHg and flow was increased in steps.
To study the effect of pharmacological inhibition of ENaC, the mesenteric arteries of C57BL/6
were incubated 10 minutes with 10−6 M of benzamil. At the end of each experiment, arterial
segments were perfused with a Ca2+-free physiological salt solution containing ethylenbis-
(oxyethylenenitrolo) tetra-acetic acid (EGTA; 2.10−3 M), papaverin (10−4 M) and SNP (10−5
M); then passive diameter of the arteries was measured at 75 mmHg [23]. Results were
expressed as the percentage of passive diameter (measured diameter/passive diameter×100).
All the chemicals were purchase from Sigma-Aldrich if not specified otherwise.
Statistical analysis
The results are reported as mean ± standard error of the mean (SEM). Data analysis was per-
formed with GraphPad Prism (V.6.04, GraphPad Software, USA). Normality of the groups
was assessed through the D’Agostino & Pearson omnibus normality test. If normality was veri-
fied, the comparison of two groups was made using a t-test. Otherwise, non-parametric Wil-
coxson-Mann Whitney U test for comparison of two groups was used. For comparison of
more than two groups, with two parameters, a two-way ANOVA with Bonferroni post-tests
was used. P values <0.05 were considered statistically significant. Asterisks refer to: P0.05;
P0.01; P0.001, P0.0001. For AFM measurements, data were calculated as
median (Q1:1
st quartile, Q3:3
rd quartile) and are displayed as box plots: mean (square), median
(horizontal line), 25th and 75th percentile (box), outlier (whiskers).
Results
Pharmacological ENaC inhibition affect vascular function
Pre-treatment with benzamil, a specific blocker of ENaC, had no effect on Phe-induced con-
traction of mesenteric arteries from C57BL/6 mice (Fig 1A). However, the endothelium-
dependent dilatory response to acetylcholine was decreased by 75% (Fig 1B). By analogy with
the other members of the ENaC/Degenerin superfamily, ENaC has been proposed to be a
mechanotransducer and we tested whether vascular ENaC could be involved in the response
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to mechanical forces induced by blood flow by measuring flow-induced vasodilation in the
absence or the presence of benzamil. As expected, increased intraluminal flow resulted in a
large augmentation in the vessels passive diameter. Pre-incubation of the vessels with benzamil
drastically blunted the flow-mediated dilation (Fig 1C) suggesting the role of endothelial
ENaC subunit in shear stress signaling.
In vivo αENaC deletion
To determine the specific role of endothelial αENaC, we generated a mouse model with tar-
geted endothelial αENaC subunit inactivation. These mice presented Mendelian ratio at birth.
mRNA expression of the αENaC subunit was decreased by 30% in the whole aorta of endo-
αENaC KO mice, as compared to control mice, while expression of the β and γENaC subunits
were not modified (Fig 2A). In order to differentiate endothelial αENaC expression from non-
endothelial αENaC expression, we compared mRNA expression of αENaC in aortas submitted
or not to the mechanical removal of the endothelium (S1 Fig). As shown in S1A Fig, expression
of αENaC was decreased in the same proportion in the control aortas without endothelium
than in the KO aortas with endothelium, suggesting that most if not all of the αENaC may
indeed be expressed in the endothelium. However, we cannot rule out small expression of
Fig 1. Effects of pharmacological inhibition of ENaC on vascular response mesenteric arteries. (A)
Vasoconstrictive response to phenylephrine (1.10−6 M), an α-adrenergic agonist. Response to phenylephrine
was not modified after inhibition of ENaC. (B) Endothelium-dependent dilatory response induced by
acetylcholine (1.10−6 M). Dilation of mesenteric arteries to Ach was decreased after benzamil preincubation.
(C) Flow-mediated dilation in response to increased intraluminal shear stress. Dilation to flow was drastically
decreased in vessels incubated with benzamil. Values are mean ± SEM (n = 3–10 for each group). *P<0.05,
***P<0.001.
https://doi.org/10.1371/journal.pone.0185319.g001
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αENaC in VSM since the removal of endothelium was not complete (as seen by the residual
expression of the endothelial marker von Willebrand Factor, S1B Fig). Since Tie2 promoter is
known to be expressed in non-endothelial cells [24], we also verified whether αENaC expres-
sion was altered in cells from the hematopoietic lineage. We did not see any differences
between the control group and the knockout group (S2 Fig).
Apical surface expression of the αENaC subunit, as determined by quantum dot labeling,
was virtually absent in the aortic endothelium of endo-αENaC KO mice, as compared to con-
trol mice (Fig 2B and S3 Fig). γENaC subunit was still present in the plasma membrane of ex
vivo endothelial cells derived from endo-αENaC KO aorta preparations (S3 Fig). Since the
endothelium function is closely related to its structure, we analyzed endothelial cell stiffness
using AFM in aortic ex vivo preparations from endo-αENaC KO and WT mice. αENaC gene
inactivation in the endothelium decreased cortical stiffness similar to benzamil treatment of
aortic preparations of control mice (Fig 2C). Taken together these data indicate that αENaC
gene deletion is efficient in endo-αENaC KO mice and that absence of endothelial αENaC
affects endothelial stiffness in intact vessels, as previously reported in cultured endothelial cells
ex vivo [15].
Fig 2. Characterization of the endo-αENaC KO mouse model. (A) Relative mRNA expression of the three
ENaC subunits in the aorta of control mice (white bars) and endo-αENaC KO mice (black bars). Expression of
the α subunit is decreased, but not those of the β and γ subunits. (B) Surface αENaC protein expression in
aortic rings. (C) Aortic cortical stiffness of endothelial cells was determined by atomic force microscope
(AFM). Values are mean ± SEM (n = 7–9 for each group). *P<0.05, ***P<0.001.
https://doi.org/10.1371/journal.pone.0185319.g002
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Physiological consequences of αENaC deletion in the vascular
endothelium
At basal state, systolic blood pressure and heart rate were similar between control and endo-
αENaC KO mice, as well as body weight, heart/tibia length and kidney/tibia length ratio
(Table 1). The structure of the vessels was not different between control and endo-αENaC KO
mice (S3 Table). Creatinine clearance was similar between control and endo-αENaC KO mice
(Table 1) as well as steady-state 24 h renal sodium excretion (urinary Na+/creatinine ratio:
10.02 ± 0.58 vs 9.43 ± 0.63). Endothelial αENaC inactivation did not affect renin RNA expres-
sion in whole kidney (renin/18S ratio: 1.00 ± 0.08 vs 1.23 ± 0.16) nor aldosterone and cortico-
sterone plasma levels (Table 1). We next analyzed whether endothelial ENaC may affect acute
renal Na+ handling. Endo-αENaC KO mice handled acute Na+ challenge similarly to control
mice: acute Na+ load or acute ENaC inhibition with amiloride increased sodium excretion to
comparable values in both groups (S4A and S4B Fig). Low salt diet decreased Na+ excretion
with the same kinetics in endo-αENaC KO mice and control mice (S4C Fig). These results
show that αENaC inactivation in vascular endothelium does not affect the classical epithelial
ENaC-dependent renal Na+ transport.
Endothelial αENaC is involved in acetylcholine-mediated endothelial
nitric oxide production
Endothelial nitric oxide (NO) production is a hallmark of endothelial function and alteration
of NO production is critical for vascular function in both physiological and pathological condi-
tions. Agonist-mediated NO production was analyzed in isolated mesenteric arteries from
control and endo-αENaC KO mice, in the presence or absence of benzamil, a pharmacological
ENaC blocker. In control mice, 10−6 M acetylcholine induced NO release which was blocked
by benzamil (Fig 3A and 3C), indicating that ENaC function contributes to physiological NO
release upon acetylcholine stimulation. In endo-αENaC KO mice, acetylcholine–mediated NO
release was similar than in control mice (Fig 3B and 3C) but the inhibitory effect of benzamil
was lost (Fig 3B and 3C).
Endothelial NO is produced by activated endothelial nitric oxide synthase (eNOS) (by
phosphorylation on the S1177 residue by phosphorylated Akt). In the aorta of endo-αENaC
KO mice, steady state phosphorylated Akt and phosphorylated eNOS (S1177) levels were higher
than in control mice (Fig 4A and 4B). This compensatory mechanism may explain similar
vasoactive responses to potassium chloride (KCl), acetylcholine and phenylephrine observed
in control and endo-αENaC KO vessels (Fig 5A–5C).
Table 1. Physiological parameters of mice.
Control
(n = 11)
Endo-αENaC KO
(n = 9)
Systolic Blood Pressure (mmHg) 113 ± 1 112 ± 2
Heart Rate (bpm) 615 ± 20 605 ± 17
Body Weight (g) 29.5 ± 0.9 30.0 ± 1.0
Tibia Lenght (mm) 18.2 ± 0.04 18.4 ± 0.09
HW/TL ratio (mg/mm) 7.45 ± 0.39 8.09 ± 0.37
KW/TL ratio (mg/mm) 19.5 ± 0.9 20.0 ± 0.9
Creatinine Clearance (ml/min) 0.53 ± 0.06 0.49 ± 0.06
Aldosteronemia (nmol/l) 0.69 ± 0.21 0.90 ± 0.23
Corticosteronemia (nmol/l) 85.5 ± 24.3 75.3 ± 19.3
HW, Heart Weight; KW, Kidney Weight; TL, Tibia Length. Values are mean ± SEM.
https://doi.org/10.1371/journal.pone.0185319.t001
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Fig 3. Consequences of ENaC blockade or gene inactivation on nitric oxide production upon
acetylcholine stimulation. Kinetic response of NO production after stimulation with acetylcholine using
fluorescent probes in mesenteric arteries of (A) control mice and (B) endo-αENaC KO mice. (C) Bar graph of
NO measurements in mesenteric arteries after incubation with or without 1.10−6 M of acetylcholine (Ach) and
1.10−7 M of benzamil (Benz) in CT (white bars) and endo-αENaC KO mice (black bars). Values are
mean ± SEM (n = 5–10 for each group). ***P<0.001.
https://doi.org/10.1371/journal.pone.0185319.g003
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Endothelial αENaC is involved in flow-mediated dilation
We next analyzed whether endothelial αENaC could be involved in vascular response to
mechanical forces induced by blood flow. A plateau of dilation response was observed at 30 μl/
min in littermate mice (Fig 5D) while the inactivation of the αENaC subunit in the endothe-
lium almost fully inhibited the flow-mediated dilation in endo-αENaC KO (Fig 5D). This result
highlights the importance of the endothelial αENaC subunit in the mechanotransduction of
shear stress into vasodilation response.
Discussion
Using a cell-specific knockout mouse model, we find two major implications of endothelial
alpha subunit of the Epithelial Sodium Channel in vascular physiology. First, we show that the
absence of αENaC expression induces to compensatory induction of phospho-eNOS and
phospho-Akt, suggesting a crucial role of αENaC in basal condition. Second, we show that
genetic deletion of the αENaC subunit in the endothelium leads to blunted flow-mediated dila-
tion in resistant arteries. While the role of ENaC in shear stress sensing has been described in
cultured human endothelial cells [8] we describe for the first time that endothelial αENaC
modulates shear stress sensing in vivo.
The expression of the three α, β, γ subunits of ENaC has been reported in the endothelium
of rat mesenteric arteries [6, 25]. The αENaC is expressed in human endothelial cells such as
the ECV 304 cell line [5] and HUVEC [26]. Distinguishing the functional implication of the
different subunits is not possible when using pharmacological ENaC blockers like amiloride or
Fig 4. Consequences of αENaC gene inactivation on endothelial nitric oxide synthase activation pathway in the aorta.
Western Blot analysis of protein expression of (A) phosphorylated Akt/total Akt ratio and total Akt/β-Actin ratio and (B)
phosphorylated eNOS (S1177)/total eNOS ratio and total eNOS/β-Actin ratio in the aorta. White bars represent control mice and
black bars represent endo-αENaC KO mice. Values are mean ± SEM (n = 9–10 for each group). *P<0.05, **P<0.01.
https://doi.org/10.1371/journal.pone.0185319.g004
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benzamil. A mouse model with endothelium-restricted αENaC subunit deletion allowed us to
test the specific role of the αENaC subunit expressed in the endothelium. We observed 30%
decreased in αENaC mRNA expression in whole aorta and no expression of αENaC protein at
the surface of the endothelial cells. After mechanical removal of the endothelium, the aortas of
the control group showed a decrease of more than 50% compared to control aortas with endo-
thelium. Removal of the endothelium did not change expression in the endo-αENaC KO group
(indicating that removal of endothelium did not change αENaC expression in the KO mice),
so we cannot rule out that the remaining αENaC mRNA expression is related to non-endothe-
lial cells. αENaC deletion did not alter the mRNA expression of the other subunits, βENaC
and γENaC. While we were unable to study βENaC expression at the surface of endothelial
cells, γENaC did not show any differences of expression between the endo-αENaC KO mice
and their littermates. γENaC was expressed at the cell membrane in the absence of αENaC sub-
unit. This was already observed in HEK-293 and COS-7 cells when γENaC was transfected in
absence of αENaC [27]. Whether γENaC alone could have a role in vascular endothelium
remains unknown.
Functional endothelial ENaC activity leads to amiloride-sensitive inward sodium current as
reported in cultured endothelial cells [6, 7]. Liu et al. recently reported functional ENaC in
Fig 5. Effects of αENaC gene inactivation on vascular response in mesenteric arteries. Vasoactive responses in mesenteric
arteries of endo-αENaC KO mice compared to their αENaC f/f control littermates. (A) Vasoconstrictive response to 8.10−2 M of
potassium chloride. (B) Vasoconstrictive response to phenylephrine (C) Endothelium-dependent dilatory response induced by
acetylcholine (D) Flow-mediated dilation in response to increased intraluminal flow. Values are mean ± SEM (n = 5–7 for each
group). *P<0.05.
https://doi.org/10.1371/journal.pone.0185319.g005
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intact endothelium of split-open rat mesenteric arteries [25]. One week of high salt diet de-
creased ENaC open probability in mesenteric arteries [25]. Decreased endothelial ENaC activ-
ity due to increased salt intake was associated with decreased eNOS phosphorylation [25].
Since reduced endothelial ENaC current induced by high salt diet was associated with an
increased acetylcholine-mediated vasorelaxation, the decrease in eNOS S1177 phosphorylation
may be a compensatory mechanism to prevent excessive relaxation [25]. Our results indicate
that acute treatment with benzamil decreased acetylcholine-mediated NO production but that
this effect was lost in endo-αENaC KO mice, which suggest an important role of endothelial
αENaC in modulating agonist-mediated NO release in physiological conditions. of note, our
western blot data were obtained in larger vessels (aorta), which might not be fully representa-
tive of mesenteric vessels, where the NO measurements where performed. Our data therefore
points to 1) that endothelial αENaC subunit is involved for the pharmacological effect of
benzamil in the vessel, 2) endothelial αENaC subunit is important for acetylcholine-induced
NO production in mice, and 3) mice lacking endothelial αENaC subunit develop compensa-
tory mechanisms to maintain NO production in response to acetylcholine. Strikingly, there
was no compensatory mechanisms for flow-mediated dilation as compared to Ach-induced
vasodilation.
The functional consequences of pharmacological inhibition of vascular ENaC on vasoreac-
tivity have been analyzed ex vivo in rat mesenteric arteries and in mouse renal interlobar arter-
ies. Perez et al. showed that acute treatment with amiloride or benzamil decreased contractile
response to phenylephrine and serotonin [6] while Liu et al. showed increased acetylcholine-
mediated vasodilation after amiloride pre-treatment [25]. In contrast, Jernigan et al. reported
no effect of benzamil on phenylephrine-induced contraction in mouse interlobar arteries [28].
We show in the present study that constitutive endo-αENaC inactivation of endothelial
αENaC in endo-αENaC KO mice does not alter contractile response, probably because com-
pensatory mechanisms develop due to long-term absence of αENaC expression/activity in the
endothelium. This suggests an important and non-redundant role of endothelial αENaC in
endothelial physiology. ENaC activity in the endothelial cells have been shown to be regulated
by some epoxyeicosatrienoic acids (EETs)[7] suggesting potential interaction with other vaso-
active agents. Further studies should analyze the role of the other ENaC subunits in the func-
tion of endothelial ENaC.
In the present study, we confirmed an important role of endothelial αENaC in endothelial
cortical cell stiffness: both pharmacological inhibition and targeted genetic inactivation of
αENaC led to decreased stiffness of endothelial cells in ex vivo aorta preparations. Interest-
ingly, we previously reported an opposite result in a mouse model with a β subunit mutation
mimicking the Liddle mutation [29] (C-terminal truncation of the β subunit and increased
endothelial surface expression of ENaC): increased endothelial ENaC surface expression led to
an increase in endothelial cortical stiffness [15]. Acetylcholine-mediated NO release is pre-
served in endo-αENaC KO mice; however, the alteration of endothelial stiffness is maintained
despite constitutive αENaC inactivation, which suggest that endothelial αENaC has a key role
of in endothelial stiffness in vivo.
The Epithelial Na channel is expressed in the vasculature but its role in vascular function
and organ damage is poorly understood. In this study, we showed that endothelial ENaC con-
tributes to the regulation of agonist-induced NO production in the vasculature. Whether
endothelial ENaC is involved in other pathologies associated with altered shear stress response,
such as atherosclerosis or renal ischemia-reperfusion remains to be analyzed. The association
of ENaC polymorphisms like the Trp493Ar or the T663A variants (which has been shown to
decrease the functional and surface expression of hENaC in oocytes) and the increased risk of
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ischemic stroke, independently of blood pressure control, points to a possible link between
αENaC and cardiovascular damage that needs to be further explored.
In conclusion, we demonstrate in this study that endothelial αENaC plays a critical role in
vascular physiology, especially for shear-stress sensing and flow-mediated dilation. It would be
important to now explore the implication of endothelial ENaC in human physiology and
pathology.
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